Coverage rules reviewed July 2026
To cover Saxenda for weight loss, most commercial plans require prior authorization documenting a BMI of 30 or higher (or 27+ with a weight-related condition such as high blood pressure or type 2 diabetes). Original Medicare and most Part D plans exclude it for weight loss by law, and many employer plans exclude weight-loss drugs entirely — so a denial is common and often appealable. Here is how each major payer handles Saxenda, and which appeal matches your denial.
What is specific to Saxenda
Saxenda is approved for weight management and nothing else, which leaves it fully exposed to the Medicare statutory exclusion with no alternative indication to fall back on. It is also outside the Bridge. At least one state Medicaid program has dropped it for every indication.
Indications other than weight loss
This is the lever most people miss. Medicare cannot pay for a drug used for weight loss — the statutory exclusion is still in force — but it can pay for a separate FDA-approved indication. The same logic applies to an employer plan that excludes weight-loss drugs. So the question is rarely “is Saxenda covered” and usually “which approved indication do I actually have?”
Saxenda has none. It is approved for weight management and nothing else, so there is no alternative indication to fall back on when a plan excludes weight-loss drugs. That makes the cash-pay routes more relevant here than the appeal routes.
Medicare GLP-1 Bridge — does not include Saxenda
The Bridge covers Wegovy (injection and tablet), the Zepbound KwikPen, and Foundayo at $50 flat per one-month supply, whatever the drug or dose. It does not include Saxenda (Ozempic, Mounjaro and Rybelsus are all outside it), so Bridge eligibility does not help a Saxenda prescription. Coverage still runs through ordinary Part D rules and your diagnosis.
Type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease disqualify you — those conditions are already covered Part D indications, so the Bridge sends you there instead.
- The $50 does not count toward your deductible or out-of-pocket cap, and Extra Help does not reduce it.
- There is no appeals process — a denied prior authorization can only be resubmitted.
- It is a time-limited demonstration, not a change in the law. Medicare still excludes weight-loss drugs by statute.
- Plans do not opt in. CMS runs it outside the Part D benefit through a central processor.
- 3.8 million Medicare beneficiaries would have met the criteria in 2023 — about 8% of Part D enrollees (KFF, June 2026).
Full detail on the program: the Medicare GLP-1 Bridge explained.
The criterion payers apply to Saxenda and not its siblings
Saxenda’s continuation threshold is 4% of baseline body weight, where Wegovy, Zepbound and Foundayo all require 5% — matching the label’s own 16-week stopping rule. It is the easiest continuation bar in the class.
Source: Cigna, Weight Loss – GLP-1 Agonists PA policy. Criteria are the named payer's published policy and vary by plan and year.
How major insurers typically cover Saxenda
Coverage varies by your specific plan (two people with the same insurer can have different benefits), changes every year, and depends on your diagnosis. Use this as a starting point, then confirm with your plan’s current formulary.
| Insurer | Typical Saxenda coverage | Full policy |
|---|---|---|
| Aetna | Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs | Aetna GLP-1 policy → |
| Blue Cross Blue Shield | Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs | Blue Cross Blue Shield GLP-1 policy → |
| UnitedHealthcare | Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs | UnitedHealthcare GLP-1 policy → |
| Cigna | Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs | Cigna GLP-1 policy → |
| Kaiser Permanente | Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs | Kaiser Permanente GLP-1 policy → |
| Medicare (Part D) | Excluded for weight loss by law; may cover for a separate FDA indication (e.g. CV risk, OSA) | Medicare (Part D) GLP-1 policy → |
| Medicaid | State-dependent — only about a dozen states cover weight-loss GLP-1s (down from a 2025 peak) | Medicaid GLP-1 policy → |
Prior authorization is the norm for GLP-1s. “Covered” almost always means “covered if your plan approves a prior-authorization request.” Verify every detail against your plan’s current formulary.
How to check your Saxenda coverage
- Call the member-services number on the back of your insurance card and ask if Saxenda is on your formulary, on which tier, and what the prior-authorization criteria are.
- Search your plan’s online drug list (formulary) for Saxenda and any step-therapy or quantity limits.
- Ask your prescriber to submit a prior-authorization request with your diagnosis and supporting documentation.
- Confirm whether your plan is fully-insured or a self-funded employer (ASO) plan — employer plans often set their own GLP-1 exclusions regardless of the insurer’s logo.
If your Saxenda claim is denied
Denials are common and often reversible. Request the written denial and the cited policy, then file an internal appeal with a letter of medical necessity; you can escalate to an independent external review. Our insurance appeal letter generator builds a starting draft. If coverage truly isn’t available, compare the cheapest cash-pay routes on the Saxenda without insurance and Saxenda cost guides.
Does my insurance cover Saxenda?
Does Aetna cover Saxenda?
Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs. Coverage is set by your specific plan and changes yearly, so confirm with Aetna using the number on your card. See our full Aetna GLP-1 coverage guide for prior-authorization criteria and appeal steps.
Does Blue Cross Blue Shield cover Saxenda?
Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs. Coverage is set by your specific plan and changes yearly, so confirm with Blue Cross Blue Shield using the number on your card. See our full Blue Cross Blue Shield GLP-1 coverage guide for prior-authorization criteria and appeal steps.
Does UnitedHealthcare cover Saxenda?
Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs. Coverage is set by your specific plan and changes yearly, so confirm with UnitedHealthcare using the number on your card. See our full UnitedHealthcare GLP-1 coverage guide for prior-authorization criteria and appeal steps.
Does Cigna cover Saxenda?
Varies by employer plan — prior auth + BMI; many plans exclude weight-loss drugs. Coverage is set by your specific plan and changes yearly, so confirm with Cigna using the number on your card. See our full Cigna GLP-1 coverage guide for prior-authorization criteria and appeal steps.
Does Medicare (Part D) cover Saxenda?
Excluded for weight loss by law; may cover for a separate FDA indication (e.g. CV risk, OSA). The Medicare GLP-1 Bridge does not change this — Saxenda is not one of the three products it covers. Coverage is set by your specific plan and changes yearly, so confirm with Medicare (Part D) using the number on your card. See our full Medicare (Part D) GLP-1 coverage guide for prior-authorization criteria and appeal steps.
Does Medicaid cover Saxenda?
State-dependent — only about a dozen states cover weight-loss GLP-1s (down from a 2025 peak). Coverage is set by your specific plan and changes yearly, so confirm with Medicaid using the number on your card. See our full Medicaid GLP-1 coverage guide for prior-authorization criteria and appeal steps.
Saxenda denied by insurance: which denial did you get?
“Denied” is four different outcomes wearing the same word, and they are not appealed the same way — one of them is barely worth appealing at all. Your denial letter says which you got; the plan is required to tell you the basis in writing. Find yours below before you spend a week on the wrong fight.
Prior authorization was never submitted, or came back incomplete
How you know it's this one: The letter says "no prior authorization on file" or lists missing documentation.
What actually moves it: This is the most common denial and the least serious: nothing about your eligibility was judged. The prescriber's office submits the PA form with the diagnosis, the clinical justification, and any labs the plan asked for. Ask them to confirm it was actually filed, and to send you the plan's PA criteria for Saxenda so you can see what has to be in it.
Step therapy — the plan wants you to fail something cheaper first
How you know it's this one: The letter names another drug you must try, or says "step therapy requirement not met".
What actually moves it: You can ask for a step-therapy exception. The grounds are clinical, not financial: you have already tried the required drug, or it is contraindicated for you, or it is expected to be ineffective given your history. Your prescriber has to make that case in writing — a patient asking on their own rarely moves it. Saxenda is increasingly not on the ladder at all — Pennsylvania Medicaid removed coverage for every indication as of January 2026. Check whether your plan still lists it before spending effort on an appeal.
The plan excludes weight-loss drugs entirely
How you know it's this one: The letter says the benefit is "not covered under your plan" rather than not medically necessary.
What actually moves it: This one is not a medical decision and an appeal usually will not move it — the employer bought a plan without the benefit. It is worth asking HR whether the exclusion has an exception process. The other route is a different diagnosis: There is no fallback. Saxenda is approved only for weight management, so a weight-loss exclusion excludes it completely, and it sits outside the Medicare Bridge as well. The manufacturer and cash-pay routes are realistic; an appeal against a benefit exclusion is not. Where neither applies, cash-pay is the realistic answer and pretending otherwise wastes your time.
The diagnosis or criteria on file do not meet the plan’s threshold
How you know it's this one: The letter cites BMI, A1c, or a comorbidity requirement you did not meet on paper.
What actually moves it: Often the clinical facts qualify but the paperwork did not carry them. Ask the plan, in writing, for the exact criteria it applied and the records it reviewed. If a qualifying comorbidity or a documented weight history was not in the file, that is what the appeal supplies.
How to get Saxenda covered by insurance
The mechanics — what to gather, how the appeal ladder works for your payer type, the exact Medicare Part D deadlines, and the distinction between a criteria denial you can win and a benefit exclusion you cannot — are the same for every GLP-1, so they live in one place rather than being restated on each drug page: GLP-1 insurance coverage.
The two steps worth repeating here, because they decide the rest: get the denial in writing with the criteria the plan applied (you are entitled to it, and you cannot appeal what you cannot read), and match the appeal to the denial type above — an appeal arguing medical necessity against a flat plan exclusion loses however well written. Your prescriber writes it; plans respond to clinical documentation from the prescribing office, and a patient letter is a supplement rather than the case. Appeal-letter generator.
GLP1Zoom is not an insurer, a pharmacy, or your prescriber, and none of this is legal or medical advice. Appeal rights and deadlines are set by your plan and by state and federal law — read your denial letter for yours, and confirm anything here with your plan and your clinician.
Editorial summary of how payers generally handle Saxenda — not a guarantee of coverage or medical/insurance advice. Always verify with your plan. Compare all insurer GLP-1 policies · Full disclaimer.